Guidelines exist for pregnant women to receive the tetanus, diphtheria and pertussis (Tdap) vaccine during weeks 27–36 to protect newborns against pertussis. Despite these guidelines, there is a gap at the clinical site in the uptake of this vaccine in this population. The purpose of this quantitative, quasi-experimental quality improvement (QI) project was to determine if or to what extent the implementation of a health care provider (HCP) educational intervention using current Centers for Disease Control (CDC) vaccine information to strongly recommend the Tdap vaccine to pregnant women would impact the Tdap vaccination rates compared to current practice among pregnant women between 27–36 weeks gestation in an urban prenatal clinic in the Southwestern United States over four weeks. The Plan, Do, Study Act (PDSA) quality improvement model provided a theoretical framework. Data on the CDC vaccine information usage to impact Tdap vaccination rates was measured by Fisher’s exact test. The baseline sample group (no intervention) (n = 22) had 15 out of 22 (68.2%) received the vaccine compared to the post-intervention sample (intervention) (n = 10) had 9 out of 10 (90%) who received the Tdap vaccine. The statistical results were not considered statistically significant (p = .38). However, there is clinical significance in the increased number of vaccines given after implementation. The results indicated the intervention may increase the Tdap vaccination rates among the prenatal population. Therefore, the recommendation is to replicate the project over a longer period of time and with a larger sample size to correlate the statistical and clinical significance.
|Commitee:||Nungaray, Karla, Mendelson, Sherri|
|School:||Grand Canyon University|
|Department:||College of Nursing and Health Care Professions|
|School Location:||United States -- Arizona|
|Source:||DAI-B 82/2(E), Dissertation Abstracts International|
|Subjects:||Nursing, Obstetrics, Medicine|
|Keywords:||CDC vaccine resources, Maternal vaccination, PDSA model, Pertussis, Prenatal Tdap vaccination, Vaccine quality improvement Project|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be